The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study. (2016)

First Author: Flasche S
Attributed to:  MRC Centre for Outbreak Analysis and Modelling Renewal funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pmed.1002181

PubMed Identifier: 27898668

Publication URI: http://europepmc.org/abstract/MED/27898668

Type: Journal Article/Review

Volume: 13

Parent Publication: PLoS medicine

Issue: 11

ISSN: 1549-1277